EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Treatment and survival of patients with malignant ovarian sex cord‐stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database

Maximilian Klar, Helmut Plett, Philipp Harter, Florian Heitz, Stefan Kommoss, Andreas Daniel Hartkopf, Marcel Grube, Eva Roser, Jalid Sehouli, Iona Braicu, Bastian Czogalla, Alexander Burges und 7 weitere

Journal of Surgical Oncology · 2023

DOI: 10.1002/jso.27248 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Surgical Oncology, 2023. Verfasst von Maximilian Klar und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Freiburg Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Granulosa Cell Tumor, Ovarian Neoplasms, Sex Cord-Gonadal Stromal Tumors, Soft Tissue Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cellgene.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malignant sex cord‐stromal cell tumours (SCST) account for only 7% of ovarian malignancies. The Arbeitsgemeinschaft fuer Gynaekologische Onkologie (AGO) study group has established a clinicopathological database to provide an overview of the current treatment strategies and survival of SCST patients and to identify research needs.

Methods

Twenty centres provided mixed retro‐ and prospective data of patients with tumour specimens and second‐opinion pathology review treated between 2000 and 2014. Descriptive analyses of treatment strategies, Kaplan–Meier curves and cox regression analyses were conducted.

Results

Two hundred and sixty‐two SCST patients were included. One hundred and ninety‐one Granulosa‐cell tumour (GCT) and 17 Sertoli‐Leydig cell tumour (SLCT) patients were stage I disease (>80%). Forty four GCT (18.7%) and two (8.3%) SLCT patients received adjuvant systemic treatment. After a median observation time of 78.2 months, 46% of all SCST patients experienced disease recurrence, treated predominantly with secondary debulking surgery (> 90%). Advanced FIGO stage, lymph node involvement and intra‐operative capsule rupture were associated with disease recurrence on univariate analysis (all p < 0.05). Median OS time was not reached.

Discussion

In this analysis of SCST patients, adjuvant chemotherapy was unable to prevent disease recurrence. Despite high recurrence rates, overall survival rates were excellent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Granulosa Cell TumorOvarian NeoplasmsSex Cord-Gonadal Stromal TumorsSoft Tissue NeoplasmsFemaleHumansLymph NodesProspective Studies

Stichwörter der Autor:innen

fertility-sparing surgerysex cord-stromal cell tumourstreatment strategies

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Freiburg Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of Gynaecology and Gynaecological Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany.
  • Department of Gynecology with Center for Oncological Surgery, Charité University Medical Center Berlin, Berlin, Germany.
  • Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany.
  • Department of Gynecology and Obstetrics, Universitätsklinikum Göttingen, Göttingen, Germany.

Förderung

  • Cellgene

Zitieren

APA

Klar, M., Plett, H., Harter, P., Heitz, F., Kommoss, S., Hartkopf, A. D., Grube, M., Roser, E., Sehouli, J., Braicu, I., Czogalla, B., Burges, A., Bossart, M., Hasanov, M. F., Link, T., Staebler, A., Mayr, D., Buderath, P., & Hasenburg, A. (2023). Treatment and survival of patients with malignant ovarian sex cord‐stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27248

Vancouver

Klar M, Plett H, Harter P, Heitz F, Kommoss S, Hartkopf AD, et al. Treatment and survival of patients with malignant ovarian sex cord‐stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database. Journal of Surgical Oncology. 2023. doi:10.1002/jso.27248

BibTeX
@article{Klar2023,
  author = {Klar, Maximilian and Plett, Helmut and Harter, Philipp and Heitz, Florian and Kommoss, Stefan and Hartkopf, Andreas Daniel and Grube, Marcel and Roser, Eva and Sehouli, Jalid and Braicu, Iona and Czogalla, Bastian and Burges, Alexander and Bossart, Michaela and Hasanov, Mir Fuad and Link, Teresa and Staebler, Annette and Mayr, Doris and Buderath, Paul and Hasenburg, Annette},
  title = {Treatment and survival of patients with malignant ovarian sex cord‐stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database},
  journal = {Journal of Surgical Oncology},
  year = {2023},
  doi = {10.1002/jso.27248}
}
Kostenlos starten →